Related Experiment Video
Updated: Apr 23, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.6K
Clinical Significance of Patient Disease Awareness in Atrial Fibrillation: Risk Profiles and Post-Ablation Outcomes
Masanaru Sawada1, Naoto Otsuka1, Koichi Nagashima1
1Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan.
Journal of Arrhythmia
|April 22, 2026
Summary
Patients with poor awareness of atrial fibrillation (AF) have higher recurrence rates after ablation. Improving patient understanding of AF is clinically significant for better outcomes.
Area of Science:
- Cardiology
- Electrophysiology
- Patient Education
Background:
- The clinical impact of patient disease awareness on risk factor control and outcomes post-atrial fibrillation (AF) ablation is not fully understood.
- Atrial fibrillation (AF) ablation is a common procedure, but long-term success can be influenced by patient factors.
- Understanding patient knowledge about AF and its management is crucial for optimizing treatment strategies.
Purpose of the Study:
- To investigate the association between patient disease awareness and clinical outcomes, including AF recurrence, after AF ablation.
- To assess the relationship between pre-ablation disease awareness and baseline patient characteristics.
- To evaluate changes in disease awareness and their correlation with clinical parameters one year post-ablation.
Main Methods:
- A prospective cohort study included 133 patients undergoing initial AF ablation.
- Disease awareness was measured using the Jessa Atrial Fibrillation Knowledge Questionnaire (JAKQ) before and one year after ablation.
- Patients were categorized into poor and good disease awareness groups based on JAKQ scores, and outcomes were compared.
Main Results:
- 31.6% of patients had poor disease awareness, associated with hypertension, diabetes, dyslipidemia, and larger left atrial volume (LAV).
- These associations persisted one year post-ablation.
- The AF/atrial tachycardia (AT) recurrence rate was significantly higher in the poor disease awareness group (23.8%) compared to the good disease awareness group (7.7%).
Conclusions:
- Poor disease awareness is linked to comorbidities and greater LAV, serving as a potential marker for AF/AT recurrence.
- These findings underscore the clinical importance of enhancing patient disease awareness for atrial fibrillation.
- Interventions aimed at improving patient understanding of AF may lead to better clinical outcomes and reduced recurrence rates.
More Related Videos
Related Concept Videos
01:23Atherosclerosis IV: Nursing Management
609
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
609
01:25Aortic Regurgitation III: Medical Management
580
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
580
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
753
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
753
01:26Atherosclerosis III: Management
634
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
634
01:25Dysrhythmias VI: Management of Dysrhythmias
593
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
593
01:30Coronary Artery Disease III: Clinical Manifestations
616
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
616